- FDA approves axitinib for advanced kidney cancer.
- Soy Isoflavone supplements did not decrease breast cancer proliferation in an RCT.
- A new journal, Cancer & Metabolism, is now accepting submissions.
- U.S. imports doxil and methotrexate to ease cancer drug shortage.
- High platelet levels are associated with poor survival in ovarian cancer patients.